Investment funds affiliated with Clayton, Dubilier & Rice and TowerBrook Capital Partners have agreed to acquire R1 RCM, a technology platform focused on supplying patient experience and financial performance for health care providers, for approximately $8.9 billion in cash. The transaction, announced Aug. 1, is expected to close by the end of the year. Clayton Dubilier was advised by a Debevoise & Plimpton team led by M&A partners Kevin Rinker, Katherine Durnan Taylor and Christopher Anthony. New York-based TowerBrook Capital was represented by a Wachtell, Lipton, Rosen & Katz team led by partners Steven A. Cohen and Victor Goldfeld. R1 RCM, which is based in Murray, Utah, was counseled by a Kirkland & Ellis team led by corporate partners Robert Hayward, Sarkis Jebejian, Brad Reed, Steven Choi and capital markets partners Ana Sempertegui and Ben Richards. Skadden, Arps, Slate, Meagher & Flom acted as legal counsel to the special committee of R1 RCM. The Skadden Arps team included partners Graham Robinson, Laura Knoll and Faiz Ahmad.
Investment Firms
August 02, 2024, 2:02 PM